Expression of cytokeratin 20 redefines urothelial papillomas of the bladder

[1]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[2]  J. Southgate,et al.  Cytokeratin 20 as an objective marker of urothelial dysplasia. , 1996, British journal of urology.

[3]  M. C. Parkinson,et al.  Transitional cell carcinoma of the bladder: diagnosis and prognosis , 1996 .

[4]  R. Sylvester,et al.  Factors affecting recurrence and progression in superficial bladder tumours. , 1995, European journal of cancer.

[5]  J. Southgate,et al.  Cytokeratin 20 expression by non‐invasive transitional cell carcinomas: potential for distinguishing recurrent from non‐recurrent disease , 1995, Histopathology.

[6]  M. Parmar,et al.  The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice. , 1995, British journal of urology.

[7]  M. Parmar,et al.  Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy , 1994, BMJ.

[8]  G. Prout,et al.  Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. , 1992, The Journal of urology.

[9]  W. Murphy,et al.  Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? , 1987, Cancer.

[10]  M. Boon,et al.  Analysis of the performance of pathologists in the grading of bladder tumors. , 1983, Human pathology.

[11]  G. Farrow,et al.  Benign papilloma or papillary carcinoma of the bladder? , 1973, The Journal of urology.

[12]  C. L. Deming.  The biological behavior of transitional cell papilloma of the bladder. , 1950, The Journal of urology.

[13]  L. Kiemeney,et al.  Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. , 1994, European journal of cancer.

[14]  S. Sternberg,et al.  Diagnostic surgical pathology , 1994 .